Apsner R, Schulenburg A, Sunder-Plassmann G, Muhm M, Keil F, Malzer R, Kalhs P, Druml W
Department of Nephrology, University of Vienna, Austria.
Bone Marrow Transplant. 1998 Jun;21(11):1149-52. doi: 10.1038/sj.bmt.1701250.
The purpose of this study was to evaluate the efficacy and safety in placement of Hickman catheters via the supraclavicular route without fluoroscopic guidance. We studied 81 consecutive percutaneous placements of dual lumen Hickman catheters via the supraclavicular route without the use of fluoroscopic guidance. Success rates, technical problems, complications, infections and reasons for explantation were recorded prospectively. Seventy-nine punctures were successful (97.5%). One pneumothorax (1.2%) and three accidental arterial punctures (3.7%) occurred. Difficulties in introducing the catheter through the peel away sheath or misplacement were not observed. The catheters remained in place for a total of 7657 days (mean 94.5, range 3-392 days). Sixteen blood cultures were positive (2.1/1000 catheter days). Five catheters (6.1%) were lost because of mechanical complications. Forty-two lines (52%) were removed electively, 23 (28.4%) because of suspected infection, and two (2.5%) because of tunnel infection. Nine patients died with a functioning catheter. We conclude that the supraclavicular approach to the subclavian vein is safe and efficient for introduction of Hickman catheters. Using this access, routine fluoroscopic or sonographic guidance is not required for proper placement. Implantation of the lines in an intensive care unit did not lead to higher infection rates than those reported in the literature.
本研究的目的是评估在无透视引导下经锁骨上途径置入Hickman导管的有效性和安全性。我们研究了81例连续经锁骨上途径在无透视引导下经皮置入双腔Hickman导管的病例。前瞻性记录成功率、技术问题、并发症、感染及拔除导管的原因。79次穿刺成功(97.5%)。发生1例气胸(1.2%)和3例意外动脉穿刺(3.7%)。未观察到导管通过剥离鞘置入困难或位置不当的情况。导管共留置7657天(平均94.5天,范围3 - 392天)。16次血培养阳性(2.1/1000导管日)。5根导管(6.1%)因机械并发症丢失。42根导管(52%)被选择性拔除,23根(28.4%)因疑似感染,2根(2.5%)因隧道感染。9例患者在导管功能正常时死亡。我们得出结论,经锁骨上途径行锁骨下静脉穿刺置入Hickman导管是安全有效的。采用这种入路,正确放置导管无需常规透视或超声引导。在重症监护病房置入导管的感染率并不高于文献报道。